Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy
S. J. Luen, R. Salgado, M. V. Dieci, A. Vingiani, G. Curigliano, R. E. Gould, C. Castaneda, T. D'Alfonso, J. Sanchez, E. Cheng, E. Andreopoulou, M. Castillo, S. Adams, S. Demaria, W. F. Symmans, S. Michiels, S. Loi
Dive into the research topics of 'Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy'. Together they form a unique fingerprint.